GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Cash From Other Investing Activities

Aptorum Group (Aptorum Group) Cash From Other Investing Activities : $0.22 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Aptorum Group's cash from other investing activities for the six months ended in Jun. 2023 was $0.45 Mil. It means Aptorum Group received $0.45 Mil from other investing activities. Aptorum Group's cash from other investing activities for the trailing twelve months (TTM) ended in Jun. 2023 was $0.22 Mil.


Aptorum Group Cash From Other Investing Activities Historical Data

The historical data trend for Aptorum Group's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Cash From Other Investing Activities Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash From Other Investing Activities
Get a 7-Day Free Trial - - - -3.36 2.63

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.36 2.86 -0.23 0.45

Aptorum Group Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptorum Group Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Industry
Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines

From GuruFocus

Aptorum Group Announces 1-for-10 Reverse Stock Split

By Business Wire Business Wire 01-20-2023